NeuBase Therapeutics (NBSE) Q2 2023 Earnings

14AugConfirmed
Dec 22
Q4 2022
Q1 2023
Q2 2023
-2.04
-1.4
-0.75
-0.11

Details

Expected EPS
N/A
Actual EPS
-2.04
Surprise EPS
-2.04
Surprise Percent
+∞%

Description

NeuBase Therapeutics (NBSE) has reported earnings of -2.04 per share for Q2 2023.

0 Comments

Share your thoughts